Blue Male Enhancement Pill, bulk product, by The Menz Club, Ridgeland, MS
Published April 24, 2013 · Recall initiated: March 10, 2012
Summary
FDA records drug Class I recall D-266-2013, published April 24, 2013 and initiated March 10, 2012. Recalling firm: The Menz Club, LLC; Status: Ongoing; Reported quantity: 50,000 capsules; Lot: None. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Marketed without an Approved NDA/ANDA; product found to contain sulfoaildenafil, an analogue of sildenafil, the active ingredient in a FDA approved product used for erectile dysfunction, making it an unapproved new drug
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- The Menz Club, LLC
- Distributor
- Utah
- Lot
- None
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAActra-SX 500 Capsules, Maximum Strength, Energizer, 500 mg, 5 count package, Body Basics, Canoga Park, CAApril 24, 2013
- FDAPublix Deli Tri Fruit and Grain Salad with red rice, red wheat, quinoa, apricots, cranberry and raisins 12oz.April 24, 2013
- FDASuprax (cefixime for oral suspension) USP, 100 mg/5 mL, 50 mL bottles (when reconstituted), Manufactured forApril 24, 2013
- FDALittle Mermaid Brand Smoked Herring.April 24, 2013
- FDALactated Ringer's and 5% Dextrose Injection, USP, 1000 mL flexible containers, Rx only, Hospira, Inc., LakeApril 24, 2013
- FDAV Maxx Rx, All Natural Male Enhancement, a) 1-count blister pack UPC Code 2802803561; b) 5-count blister packAugust 29, 2012
Questions about this recall
Was Blue Male Enhancement Pill, bulk product, by The Menz Club, Ridgeland, MS recalled?
Yes. FDA published recall D-266-2013 on April 24, 2013. Reported hazard: Marketed without an Approved NDA/ANDA; product found to contain sulfoaildenafil, an analogue of sildenafil, the active ingredient in a FDA approved product used for erectile dysfunction, making it an unapproved new drug
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail